Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Rock

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Current Oncology (Toronto, Ont.)|May 26, 2026
<i>STK11</i> as an Emerging Biomarker in Non-Small Cell Lung CancerAmit A Kulkarni, Adam Rock, Matthew Lee, et al.
Cancers|April 14, 2025
Treatment Approaches for Oligoprogressive Non-Small Cell Lung Cancer: A Review of Ablative RadiotherapyWilliam Gombrich, Nicholas Eustace, Yufei Liu, et al.
Therapeutic Advances in Medical Oncology|September 25, 2023
Role of immunotherapy in chondrosarcoma: A case report and review of the literatureAdam J Cohen-Nowak, Danielle B Dressler, Adam Rock, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase InhibitionAdam Rock, Isa Mambetsariev, Siddhika Pareek, et al.
Clinical Lung Cancer|September 15, 2023
Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung CancerMaryam Ebadi, Colton Ladbury, Jason Liu, et al.
Eclinicalmedicine|October 7, 2025
Osimertinib plus consolidative radiotherapy for advanced <i>EGFR</i> mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trialSagus Sampath, Sawsan Rashdan, Puneeth Iyengar, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
JAMA Network Open|April 29, 2024
Barriers to Clinical Trial Implementation Among Community Care CentersHedyeh Ebrahimi, Sandra Megally, Elana Plotkin, et al.
The Oncologist|March 27, 2023
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort AnalysisLuis Meza, Zeynep Zengin, Sabrina Salgia, et al.
JCO Precision Oncology|March 2, 2026
Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell TumorsRebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Current Oncology (Toronto, Ont.)|May 26, 2026
<i>STK11</i> as an Emerging Biomarker in Non-Small Cell Lung CancerAmit A Kulkarni, Adam Rock, Matthew Lee, et al.
Cancers|April 14, 2025
Treatment Approaches for Oligoprogressive Non-Small Cell Lung Cancer: A Review of Ablative RadiotherapyWilliam Gombrich, Nicholas Eustace, Yufei Liu, et al.
Therapeutic Advances in Medical Oncology|September 25, 2023
Role of immunotherapy in chondrosarcoma: A case report and review of the literatureAdam J Cohen-Nowak, Danielle B Dressler, Adam Rock, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase InhibitionAdam Rock, Isa Mambetsariev, Siddhika Pareek, et al.
Clinical Lung Cancer|September 15, 2023
Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung CancerMaryam Ebadi, Colton Ladbury, Jason Liu, et al.
Eclinicalmedicine|October 7, 2025
Osimertinib plus consolidative radiotherapy for advanced <i>EGFR</i> mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trialSagus Sampath, Sawsan Rashdan, Puneeth Iyengar, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
JAMA Network Open|April 29, 2024
Barriers to Clinical Trial Implementation Among Community Care CentersHedyeh Ebrahimi, Sandra Megally, Elana Plotkin, et al.
The Oncologist|March 27, 2023
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort AnalysisLuis Meza, Zeynep Zengin, Sabrina Salgia, et al.
JCO Precision Oncology|March 2, 2026
Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell TumorsRebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
Pageof 3